The researchers aimed to describe the prevalence of pre-cluster (premonitory) symptoms and examine the predictability of an upcoming cluster headache bout.
A team of researchers conducted a systematic review to examine the association between migraine and lipid profile differences.
The Clinical Trials Subcommittee of the IHS penned this statement to facilitate the development of an evidence base for new medications and devices for migraine treatment.
Patients with migraine, headache, or occipital neuralgia who underwent greater occipital nerve decompression surgery had abnormal tissue structure.
The first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention has been published in Cephalalgia by the Clinical Trials Subcommittee of the International Headache Society.
A woman presents to the ED with a headache that is unlike the migraines she typically experiences. Can you make the correct diagnosis?
The investigators explored the relationships between headache frequency and characteristics, medication use, and quality of life in patients with chronic migraine and medication overuse headache.
INP104 uses proprietary technology to deliver a lower dose of dihydroergotamine mesylate (DHE) to the upper nasal space.
The objective of this post hoc analysis is to better assess the benefits of fremanezumab in patients who responded to treatment during 2 phase 3 HALO clinical trials.
Examining the evidence suggesting associations between migraine and major depressive disorder (MDD).